AUG 24, 2021 5:00 AM PDT

A New Chapter in Metastatic Breast Cancer Biomarkers

WRITTEN BY: Tara Fernandez

For patients diagnosed with metastatic breast cancer, it’s often not the primary tumor that has fatal consequences, but metastases that have taken hold in essential organs such as the lungs and the brain. 

Ultimately, the ability to spot the signs of metastasis early has immense life-saving potential for these patients—responding quickly with intensive therapeutic interventions could prevent cancerous cells from breaking off and spreading away from malignant breast tissue.

In a breakthrough study, a team of cancer researchers from Tel Aviv University profiled the genetic makeup of cancer cells, revealing never-before-seen gene signatures that represent novel metastatic breast cancer biomarkers.

The scientists were interested in one particular cell type known to be a central player in breast cancer metastases: Cancer-associated fibroblasts. These cells are typically found in the peripheral regions of solid breast tumors. Until now, however, how these fibroblasts influence the journey of cancer cells to distant sites away from the primary tumor has remained a black box. 

In the study, the team used a specialized mouse model, genetically engineered to allow the researchers to watch, track, and profile cancer-associated fibroblasts in spontaneous lung metastasis. 

Interestingly, by generating full genetic profiles of these metastatic cells alongside those from healthy lung tissues, the investigators were able to draw out distinct gene expression profiles associated with early and late metastatic disease. These important findings shed light on how cancer cells grow and the subtle changes occurring in the tumor microenvironment at every stage of metastasis.

Most critically, these profiles can be used as diagnostic reference points to gain insights on the nature of breast tumor biopsies taken from cancer patients. Patients most at risk of cancer progression can undergo more aggressive interventions to slow—or ideally, completely block—breast cancer metastasis.

Speaking on the significance of this future clinical application, lead researcher Neta Erez said: “Understanding the body’s preparation for the reception of metastases at an early stage may save millions of lives.”

 


Source: eLife, Tel Aviv University News.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAY 06, 2021
Clinical & Molecular DX
Using Biology as Technology: A Paradigm Shift
MAY 06, 2021
Using Biology as Technology: A Paradigm Shift
Digital networks have changed the world by integrating into almost every aspect of our lives, but they have yet to direc ...
MAY 18, 2021
Genetics & Genomics
Library Prep Methods for SARS-CoV-2 Sequencing: a Summary
MAY 18, 2021
Library Prep Methods for SARS-CoV-2 Sequencing: a Summary
As the SARS-CoV-2 virus continues to mutate, rapid sequencing of COVID-19-positive samples is more critical than ever. N ...
JUN 08, 2021
Genetics & Genomics
Primers and Probes to Assay for SARS-CoV-2 Variants in Research Samples
JUN 08, 2021
Primers and Probes to Assay for SARS-CoV-2 Variants in Research Samples
Today, many scientists are investigating SARS-CoV-2 variants in their research projects. In order to facilitate screenin ...
JUL 29, 2021
Genetics & Genomics
Obesity May Not Always Lead to Disease
JUL 29, 2021
Obesity May Not Always Lead to Disease
Some gene variants might be protecting people from the negative health effects of obesity.
SEP 01, 2021
Clinical & Molecular DX
Will Childhood Cancer Survivors Go On to Have Broken Hearts?
SEP 01, 2021
Will Childhood Cancer Survivors Go On to Have Broken Hearts?
Patients are seven times more likely to have a heart attack or stroke than the general population after receiving treatm ...
SEP 16, 2021
Drug Discovery & Development
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
SEP 16, 2021
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
According to the Population Reference Bureau, 40 million people in the United States are aged 65 and older. This nu ...
Loading Comments...